Abstract: A magnetic card (10) has a base card (11), a magnetic stripe (12) formed on the base card (11), and a plurality of optical fibers (15) extended within the base card (11) substantially perpendicularly to the magnetic stripe (12). The magnetic stripe (12) consists of an arrangement of a plurality of unit magnetic segments (12a) each having a recording capacity of a predetermined number of bits, for example, eleven bits. The optical fibers (15) are assigned to the unit magnetic segments (12a), respectively. A read/write head (23) reads magnetic information from the magnetic stripe (12), an optical read device including a light-emitting device (20) and a light-receiving device (22) read optical information from the optical fibers (15), and a controller (25) examines the magnetic information with reference to the optical information to authenticate the magnetic information.

Abstract: An azole derivative represented by the following general formula (I) ##STR1## (symbols in the formula have the following meanings; R.sup.1 and R.sup.2 : the same or different from each other and each represents a hydrogen atom, a lower alkyl group or a phenyl group which may be substituted with a halogen atom,A, B and D: the same or different from one another and each represents a group represented by the formula ##STR2## or a nitrogen atom,X and Y: the same or different from each other and each represents a single bond, a methylene group, an oxygen atom,a group represented by a formula S(O).sub.n, or a group represented by the formula ##STR3## R.sup.3 and R.sup.4 : the same or different from each other and each represents a hydrogen atom or a lower alkyl group, andn: 0, 1 or 2),a salt thereof, a hydrate thereof or a solvate thereof.

Abstract: A triazolylated tertiary amine compound represented by general formula (I) or a salt thereof, having an aromatase inhibitory activity and being useful for preventing and treating breast cancer, mastopathy, endometriosis, prostatomergaly, etc., wherein A represents a single bond, lower alkylene or carbonyl; B represents lower alkyl, aryl, a 5- or 6-membered heterocyclic group, or a bicyclic fused heterocyclic group; D represents aryl, a 5- or 6-membered heterocyclic group, or a bicyclic fused heterocyclic group; and E represents 4H-1,2,4-triazolyl, 1H-1,2,4-triazolyl or 1H-1,2,3-triazolyl.

Abstract: A process is provided for producing diastereoisomer A or a pharmaceutically acceptable acid addition salt of 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-(1-benzylpyrrolidin-3-yl) ester 5-methyl ester which comprises subjecting a mixture of diastereoisomers A and B of 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-(1-benzylpyrrolidin-3-yl) ester 5-methyl ester to column chromatography using silica gel as a carrier and a mixture of ethyl acetate and acetic acid as an eluant, and then separating the acetate of diastereoisomer A from the eluate, or treating the acetate with a base, or further treating the resulting diastereoisomer A with a pharmaceutically acceptable acid.

Abstract: Carbostyril derivatives useful for inhibiting the adhesion of platelets represented by general formula ##STR1## [wherein, R.sup.1 is a hydrogen atom, a fluorine atom or a methyl group; R is a group of the formula ##STR2## (R.sup.2 is a methyl group, a trifluoromethyl group or a nitro group), or a group of the formula ##STR3## (R.sup.3 is a fluorine atom and p is an integer of 2 or 3); and n is an integer of 2 or 3], or salts thereof.Said carbostyril derivatives or salts are useful as an agent for inhibiting the adhesion of platelets.

Abstract: A substituted tertiary amino compound represented by general formula (I) or a pharmaceutically acceptable salt thereof. They have an aromatase inhibiting activity and are useful as a prophylactic and/or therapeutic agent for breast cancer, mastopathy, endometriosis, prostatic-hypertrophy, and so forth.

Abstract: A controlled release-initiation and controlled release-rate pharmaceutical composition in which a drug-containing composition is coated with a membrane layer comprising a water insoluble high polymer and silicone. The starting time for the release of drugs from the controlled release-initiation and controlled release-rate pharmaceutical composition of this invention and the drug-releasing rate thereafter can be controlled at will.

Abstract: A dextro-rotatory optical isomer of diastereoisomer A of (.+-.)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-(1-benzylpyrrolidin-3-yl)ester 5-methyl ester is provided having the formula ##STR1## and wherein the melting point of the hydrochloride of the dextro-rotatory optical isomer is 223.degree. to 230.degree. C. (decomp.), or a pharmaceutically acceptable acid addition salt thereof.

Abstract: The diastereoisomer A of a dihydropyridine-3,5-dicarboxylic acid ester derivative is provided as well as its pharmaceutically acceptable acid addition salts. The invention further discloses a process for producing the compounds and their use as medicaments in imparting vasodilating activity.

Abstract: An apparatus for holding an insertable part of an endoscope positioned in a combustion chamber of a reciprocating engine or rotary engine having ignition plug holes to observe the interior of the combustion chamber and an inspecting method are provided with a holding apparatus for stationarily holding the insertable part in the combustion chamber through a spark plug hole provided in the engine to insert a spark plug for a spark plug ignition into the combustion chamber.

Abstract: The endoscope system of this invention is formed of an endoscope having an insertable part provided in the tip part with an illuminating window and a receiving window receiving an object image illuminated by an illuminating light emitted from the illuminating window and a plurality of sheaths selectively and removably connected to the endoscope, inserted through the insertable part when connected to the endoscope and having respectively different functions.

Abstract: Compressed molded preparations are disclosed. In the preparation coated granules of a pharmaceutical composition are compressed and molded together with non-coated component(s) containing 10% or more by weight of non-swelling polymers. According to the preparation there is little breakdown of the coating of coated granules at the time of compressing and molding, and the rate of disintegration, and in turn, the release rate of the pharmaceutical component, can be freely controlled or modulated.

Abstract: Compressed-molded preparations are disclosed. In the preparation coated granules of a pharmaceutical composition are compressed and molded together with non-coated component(s) containing 10% or more by weight of non-swelling polymers. According to the preparation there is little breakdown of the coating of coated granules at the time of compressing and molding, and the rate of disintegration, and in turn, the release rate of the pharmaceutical component, can be freely controlled or modulated.

Abstract: A rotary support device comprising an under ring including a horizontal portion and a peripheral wall, the wall projecting upward from the inner periphery of the horizontal portion and being inclined either outward or inward, the wall being formed with a guide groove in a peripheral surface thereof, and an upper ring including a horizontal portion and a peripheral wall, the upper ring wall projecting downward from the inner periphery of the horizontal portion and being inclined along the inclined under ring wall, the upper ring wall being formed with a guide groove in a peripheral surface thereof. The two rings are fitted to each other with a row of balls rollably fitted in their respective guide grooves. The grooved wall portion of each ring has a side edge partially covering the balls from above or below in engagement therewith. The two rings are engaged with each other inseparably and rotatably by the balls.

Abstract: A sustained-release tablet is disclosed. The tablet is a combination of powder (A) comprising an oil component, water insoluble polymer, or both, and a pharmaceutically active component and powder (B) comprising a water soluble polymer and a pharmaceutically active component. An ideal release rate for individual pharmaceutically active component can easily be ensured by controlling its release rate by changing the ratio of powders (A) and (B).

Abstract: Disclosed is an industrial endoscope system having a rotary treatment member, attached to a hard top part at a distal end of an insertion unit, for effecting a treatment such as grinding by rotating this treatment member itself. The system includes a moving means for making a distal end of the treatment member movable in the axial directions of the insertion unit. This easily leads the treatment member to a target position via a lead-in port of an engine; or the treatment member can be set in a position suitable for the treatment.

Abstract: A wear-resistant titanium alloy containing titanium carbides which are crystallized and/or precipitated and are dispersed in the .beta.-phase matrix is disclosed. The alloy may further comprise .alpha.-phase and/or additional hard particles dispersed in the .beta.-phase matrix.

Abstract: An eddy current flaw detecting endoscope apparatus has an endoscope having an elongate insertable part and an objective optical system provided on the tip side of the insertable part. A flaw detecting device is provided on the tip side of the endoscope. A signal processing device processes a signal for the flaw detecting device. An eddy current flaw detecting apparatus detects a flaw in an object to be inspected and generates a flaw detecting signal. A controlling device generates a control signal controlling a controlled device with a flaw detecting signal of the eddy current flaw detecting apparatus.

Abstract: A borescope apparatus comprising a flexible insertion section, a jet port formed at the insertion section, a moving device for supplying a compressed fluid to the jet port, whereby the insertion section is moved by an impellent force of the fluid ejected from the jet port, and a stabilizing device for steadily maintaining the position of the insertion section.

Abstract: A wear-resistant titanium alloy containing titanium carbides which are crystallized and/or precipitated and are dispersed in the .beta.-phase matrix is disclosed. The alloy may further comprise .alpha.-phase and/or additional hard particles dispersed in the .beta.-phase matrix.